A mobile phone-based miniature microscopic image acquisition device, and image stitching and recognition methods are provided. The acquisition device comprises a support, wherein a mobile phone fixing table is provided on the support. A microscope head is provided below a camera of a mobile phone. A slide holder is provided below the microscope head, and an lighting source is provided below the slide holder. A scanning movement is performed between the slide holder and the microscope head along X and Y axes, so that images of a slide are acquired into the mobile phone. The slide sample images acquired into the mobile phone can be stitched and recognized, and can be uploaded to the cloud to be processed by cloud AI, thereby significantly improving the accuracy and efficiency of cell recognition, greatly reducing the medical cost, and ensuring more remote medical institutions can apply such technology for diagnosis.

A urine analysis system according to an embodiment includes: a testing apparatus that measures particles included in a urine sample according to a flow cytometry method; an image capturing apparatus that captures images of particles in the urine sample to acquire particle images; and a management apparatus that receives a measurement result obtained by the testing apparatus and the particle images acquired by the image capturing apparatus. The management apparatus generates an order to capture an image of the urine sample based on the measurement result obtained by the testing apparatus. The image capturing apparatus executes the image capturing processing of the particles in the urine sample for which the image capturing order has been generated by the management apparatus, and transmits the acquired particle images to the management apparatus.

A system includes a microscope configured to magnify a pathology sample, a camera positioned to record magnified pathology images from the microscope, and a display configured to show the magnified pathology images. A processing apparatus is coupled to the camera, and the display, and the processing apparatus includes instructions that when executed by the processing apparatus cause the system to perform operations, including: identifying, using a machine learning algorithm, one or more regions of interest in the magnified pathology images; and alerting, using the display, a user of the microscope to the one or more regions of interest in the magnified pathology images while the pathology sample is being magnified with the microscope.

A biological tissue analyzing device configured to analyze a biological tissue using hyperspectral data in which spectral information is associated with each of pixels forming a two-dimensional image and comprising the following (i) and (ii), as well as comprising (iii) and/or (iv): (i) a hyperspectral data acquisition unit configured to acquire the hyperspectral data; (ii) an analysis target region extraction unit configured to extract pixels corresponding to an analysis target region from a two-dimensional image of the biological tissue; (iii) an altered state classification unit configured to roughly classify an altered state of the biological tissue with unsupervised learning; and (iv) an altered state identification unit configured to identify the altered state of the biological tissue with supervised learning.

A classification training method for training classifiers adapted to identify specific mutations associated with different cancer including identifying driver mutations. First cells from mutation cell lines derived from conditions having the number of driver mutations are acquired and 3D image feature data from the number of first cells is identified. 3D cell imaging data from the number of first cells and from other malignant cells is generated, where cell imaging data includes a number of first individual cell images. A second set of 3D cell imaging data is generated from a set of normal cells where the number of driver mutations are expected to occur, where the second set of cell imaging data includes second individual cell images. Supervised learning is conducted based on cell line status as ground truth to generate a classifier.

Disclosed is a computer-implemented method which encompasses registering a tracked imaging device such as a microscope having a known viewing direction and an atlas to a patient space so that a transformation can be established between the atlas space and the reference system for defining positions in images of an anatomical structure of the patient. Labels are associated with certain constituents of the images and are input into a learning algorithm such as a machine learning algorithm, for example a convolutional neural network, together with the medical images and an anatomical vector and for example also the atlas to train the learning algorithm for automatic segmentation of patient images generated with the tracked imaging device. The trained learning algorithm then allows for efficient segmentation and/or labelling of patient images without having to register the patient images to the atlas each time, thereby saving on computational effort.

An imaging flow cytometer device includes a housing holding a multi-color illumination source configured for pulsed or continuous wave operation. A microfluidic channel is disposed in the housing and is fluidically coupled to a source of fluid containing objects that flow through the microfluidic channel. A color image sensor is disposed adjacent to the microfluidic channel and receives light from the illumination source that passes through the microfluidic channel. The image sensor captures image frames containing raw hologram images of the moving objects passing through the microfluidic channel. The image frames are subject to image processing to reconstruct phase and/or intensity images of the moving objects for each color. The reconstructed phase and/or intensity images are then input to a trained deep neural network that outputs a phase recovered image of the moving objects. The trained deep neural network may also be trained to classify object types.

Automation of microscopic pathological diagnosis relies on digital image quality, which, in turn, affects the rates of false positive and negative cellular objects designated as abnormalities. Cytogenetic biodosimetry is a genotoxic assay that detects dicentric chromosomes (DCs) arising from exposure to ionizing radiation. The frequency of DCs is related to radiation dose received, so the inferred radiation dose depends on the accuracy of DC detection. To improve this accuracy, image segmentation methods are used to rank high quality cytogenetic images and eliminate suboptimal metaphase cell data in a sample based on novel quality measures. When sufficient numbers of high quality images are found, the microscope system is directed to terminate metaphase image collection for a sample. The International Atomic Energy Agency recommends at least 500 images be used to estimate radiation dose, however often many more images are collected in order to select the metaphase cells with good morphology for analysis. Improvements in DC recognition increase the accuracy of dose estimates, by reducing false positive (FP) DC detection. A set of chromosome morphology segmentation methods selectively filtered out false DCs, arising primarily from extended prometaphase chromosomes, sister chromatid separation and chromosome fragmentation. This reduced FPs by 55% and was highly specific to the abnormal structures (≥97.7%). Additional procedures were then developed to fully automate image review, resulting in 6 image-level filters that, when combined, selectively remove images with consistently unparsable or incorrectly segmented chromosome morphologies. Overall, these filters can eliminate half of the FPs detected by manual image review. Optimal image selection and FP DCs are minimized by combining multiple feature based segmentation filters and a novel image sorting procedure based on the known distribution of chromosome lengths. Consequently, the average dose estimation error was reduced from 0.4 Gy to <0.2 Gy with minimal manual review required. Automated image selection with these filters reduces the number of images that are required to capture metaphase cells, thus decreasing the number of images and time required for each sample. A microscope system integrates image selection procedures controls with an automated digitally controlled microscope then determines at what point a sufficient number of metaphase cell images have been acquired to accurately determine radiation dose, which then terminates data collection by the microscope. These image filtering approaches constitute a reliable and scalable solution that results in more accurate and rapid radiation dose es

Systems and methods for using quantitative ultrasound (“QUS”) techniques to generate imaging biomarkers that can be used to assess a prediction of tumor response to different chemotherapy treatment regimens are provided. For instance, the imaging biomarkers can be used to subtype tumors that have resistance to certain chemotherapy regimens prior to drug exposure. These imaging biomarkers can therefore be useful for predicting tumor response and for assessing the prognostic value of particular treatment regimens.

A method comprising receiving images depicting stained target tissue, segmenting the images into cell type and region type segmentations, extracting cell phenotype features from an analysis of the stains for cell type segmentations, clustering the cell type segmentations, computing feature vectors each including the respective cell phenotype features, and an indication of a location of the cell type segmentation relative to region type segmentation(s), creating a cell-graph based on the feature vectors of cell type segmentations and/or clusters, wherein each node denotes respective cell type segmentation and/or respective cluster and includes the feature vector, and edges represent a physical distance between cell type segmentations and/or clusters corresponding to the respective nodes, inputting the cell-graph into a graph neural network, and obtaining an indication of a target therapy likely to be effective for treatment of medical condition in the subject as an outcome of the graph neural network.